Discover how new U.S. Medicare drug price cuts impact major pharma stocks like Novo Nordisk and why sector resilience ...

Novo Nordisk is also currently awaiting a decision from the FDA, having previously applied for approval of its Wegovy weight-loss pill. As part of the U.S. pricing deal with the administration earlier ...

The program, which is being piloted in three prisons, will provide Medicaid-funded care to eligible soon-to-be-released inmates.

The U.S. Centers for Medicare & Medicaid Services (CMS) rolled out the negotiated costs of the second batch of drugs subject to such bargaining. CMS said the adjusted maximum fair prices would have ...

Medicare will announce negotiated prices for 15 high-cost drugs, impacting over 67 million beneficiaries. The Inflation ...

More than two thirds of therapists approved to treat children had not undergone full background checks, an internal review ...

The government shutdown ended with a failure to solve the problem of steeply rising health insurance premiums. The GOP’s “Big Beautiful Bill,” which ...

As Colorado weighs potential reductions to Medicaid services, the state's largest Medicaid administrator says providers are ...

The Idaho Department of Health and Welfare is seeking public comment through a statewide survey that’s open through Dec. 31, ...

A US study of more than a million Medicaid enrollees newly diagnosed with opioid use disorder (OUD), finds most—nearly seven ...

By Phil Galewitz for KFF Health News. Broadcast version by Trimmel Gomes for Mississippi News Connection reporting for the ...

Management increased full-year 2025 adjusted EPS guidance to $21.80 per diluted share, up from $20.50 previously, citing operational performance and supplemental Medicaid reimbursement as primary ...